Learn about the critical aspects of neuromuscular blocking drugs and reversal agents in this 59-minute webinar that addresses the concerning rise in residual and recurrent neuromuscular block cases. Explore how the transition from long-acting agents like tubocurarine and pancuronium to atracurium and vecuronium initially reduced complications, but recent challenges have emerged due to improper dosing of rocuronium and sugammadex. Gain valuable insights into best practices for administering neuromuscular blocking drugs, understand the significance of appropriate reversal agent dosing, and discover why quantitative neuromuscular monitoring is essential for patient safety during neuromuscular blockade procedures.